Covered recipient · General Payments record
ERICA DAVENPORT
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecology
General Payments · PY2018–2024
$13,743.12
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $800.00 | 1 |
| Food and Beverage | $355.24 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Caldera Medical, Inc | $905.93 | 2 |
| Organon LLC | $78.55 | 3 |
| PFIZER INC. | $42.30 | 2 |
| Sumitomo Pharma America, Inc. | $26.35 | 1 |
| MILLICENT US INC | $24.28 | 1 |
| Hologic Sales and Service, LLC | $21.20 | 1 |
| ABBVIE INC. | $15.85 | 1 |
| CooperSurgical, Inc. | $13.78 | 1 |
| Channel Medsystems, Inc. | $13.52 | 1 |
| Astellas Pharma US Inc | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.85 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605210 | CMS |
| Astellas Pharma US Inc | $13.48 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139303188 | CMS |
| Caldera Medical, Inc | $800.00 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136348586 | CMS |
| Caldera Medical, Inc | $105.93 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136347372 | CMS |
| Channel Medsystems, Inc. | $13.52 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067477937 | CMS |
| CooperSurgical, Inc. | $13.78 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150800954 | CMS |
| Hologic Sales and Service, LLC | $21.20 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084882564 | CMS |
| MILLICENT US INC | $24.28 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150906138 | CMS |
| Organon Llc | $27.51 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136299336 | CMS |
| Organon Llc | $26.64 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136299340 | CMS |
| Organon Llc | $24.40 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136299344 | CMS |
| PFIZER INC. | $16.21 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131826236 | CMS |
| PFIZER INC. | $26.09 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131639533 | CMS |
| Sumitomo Pharma America, Inc. | $26.35 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148843055 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.